The Cooper Companies, Inc.
NMS: COOLive Quote
📈 ZcoreAI Score
Our AI model analyzes The Cooper Companies, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get COO Z-Score →About The Cooper Companies, Inc.
Healthcare
Medical Instruments & Supplies
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
📊 Fundamental Analysis
The Cooper Companies, Inc. demonstrates a profit margin of 9.7%, which is below the sector average, suggesting competitive pressure.
The company recently reported 6.2% revenue growth, which is modest compared to its industry peers.
Return on Equity (ROE) is 4.9%, which suggests room for improvement in capital utilization.
At a current price of $71.21, COO currently sits at the 34th percentile of its 52-week range (Range: $61.78 - $89.83).
💰 Valuation Insight
COO trades at a 41.7% premium to the sector average PE of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$13.89B
Trailing P/E
35.43
Forward P/E
14.19
Beta (5Y)
1.07
52W High
$89.83
52W Low
$61.78
Avg Volume
2.02M
Day High
Day Low